CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Delcath Systems, Inc. - DCTH CFD

11.55
3.02%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 11.91
Open 11.82
1-Year Change 272.87%
Day's Range 11.53 - 11.86
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 11.91 -0.17 -1.41% 12.08 12.24 11.79
Dec 16, 2024 12.20 0.42 3.57% 11.78 13.24 11.63
Dec 13, 2024 12.09 0.31 2.63% 11.78 12.31 11.73
Dec 12, 2024 11.76 -0.53 -4.31% 12.29 12.31 11.74
Dec 11, 2024 12.20 0.60 5.17% 11.60 12.29 11.45
Dec 10, 2024 11.62 0.14 1.22% 11.48 11.84 11.45
Dec 9, 2024 11.53 -0.33 -2.78% 11.86 12.03 11.33
Dec 6, 2024 11.81 0.38 3.32% 11.43 11.87 11.41
Dec 5, 2024 11.46 0.07 0.61% 11.39 11.75 11.39
Dec 4, 2024 11.41 -0.34 -2.89% 11.75 11.93 11.38
Dec 3, 2024 11.81 -0.68 -5.44% 12.49 12.53 11.54
Dec 2, 2024 12.61 1.13 9.84% 11.48 12.75 11.32
Nov 29, 2024 11.71 0.53 4.74% 11.18 11.94 11.13
Nov 27, 2024 11.20 0.66 6.26% 10.54 11.24 10.52
Nov 26, 2024 10.62 0.14 1.34% 10.48 10.72 10.26
Nov 25, 2024 10.46 0.72 7.39% 9.74 10.51 9.74
Nov 22, 2024 9.72 -0.13 -1.32% 9.85 9.97 9.31
Nov 21, 2024 9.81 0.28 2.94% 9.53 9.94 9.53
Nov 20, 2024 9.60 -0.28 -2.83% 9.88 10.09 9.50
Nov 19, 2024 9.87 0.24 2.49% 9.63 9.99 9.56

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Delcath Systems, Inc. Company profile

About Delcath Systems Inc

Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.

Equity composition

Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.

Industry: Medical Prosthetics

1633 Broadway Ste 22C
NEW YORK
NEW YORK 10019-6708
US

People also watch

ETH/USD

3,869.41 Price
-1.670% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

BTC/USD

104,210.30 Price
-2.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,636.12 Price
-0.410% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,988.50 Price
+0.050% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading